Pages that link to "Q73367289"
Jump to navigation
Jump to search
The following pages link to Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram (Q73367289):
Displaying 26 items.
- Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme (Q28357383) (← links)
- Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo (Q28366560) (← links)
- Cyclic AMP dysregulates intestinal epithelial cell restitution through PKA and RhoA (Q31034056) (← links)
- Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide (Q33359767) (← links)
- In vivo imaging reveals PKA regulation of ERK activity during neutrophil recruitment to inflamed intestines (Q33702929) (← links)
- Multiple Phenotypic Changes Define Neutrophil Priming (Q33734931) (← links)
- Fluid shear stress increases neutrophil activation via platelet-activating factor (Q33736487) (← links)
- Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? (Q33871349) (← links)
- Putting priming into perspective - from cellular heterogeneity to cellular plasticity (Q33899278) (← links)
- Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation (Q33906531) (← links)
- Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors (Q33957185) (← links)
- Bradykinin down-regulates LPS-induced eosinophil accumulation in the pleural cavity of mice through type 2-kinin receptor activation: a role for prostaglandins (Q35028877) (← links)
- A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury. (Q35040399) (← links)
- EP4 receptor stimulation down-regulates human eosinophil function. (Q35332774) (← links)
- Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease (Q37332621) (← links)
- PDE4 inhibitors - a review of the current field (Q37425642) (← links)
- An estimation of beta 2-adrenoceptor reserve on human bronchial smooth muscle for some sympathomimetic bronchodilators (Q37481283) (← links)
- The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function (Q37632467) (← links)
- Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells (Q39081937) (← links)
- Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability. (Q39322017) (← links)
- Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation (Q41888439) (← links)
- Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors (Q43574339) (← links)
- Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils (Q44415054) (← links)
- Induction of reactive oxygen species in bovine neutrophils is CD11b, but not dectin-1-dependent (Q45020782) (← links)
- A pathophysiological role of PDE3 in allergic airway inflammation. (Q49030605) (← links)
- The influence of prostaglandins on leukocyte-endothelium interactions in rabbit mesenteric venules (Q73461580) (← links)